|
1
|
Patel T: Cholangiocarcinoma. Nat Clin
Pract Gastroenterol Hepatol. 3:33–42. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhao W, Zhang B, Guo X, Zhang X, Hu J, Hu
X and Lu Y: Expression of Ki-67, Bax and p73 in patients with hilar
cholangiocarcinoma. Cancer Biomark. 14:197–202. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chauhan A, House MG, Pitt HA, Nakeeb A,
Howard TJ, Zyromski NJ, Schmidt CM, Ball CG and Lillemoe KD:
Post-operative morbidity results in decreased long-term survival
after resection for hilar cholangiocarcinoma. HPB (Oxford).
13:139–147. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cheng Y, Chen Y and Chen H: Application of
portal parenchyma-enterostomy after high hilar resection for
Bismuth type IV hilar cholangiocarcinoma. Am Surg. 76:182–187.
2010.PubMed/NCBI
|
|
5
|
Liu Y, Su ZW, Li G, Yu C, Ren S, Huang D,
Fan S, Tian Y, Zhang X and Qiu Y: Increased expression of
metadherin protein predicts worse disease-free and overall survival
in laryngeal squamous cell carcinoma. Int J Cancer. 133:671–679.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hu G, Wei Y and Kang Y: The multifaceted
role of MTDH/AEG-1 in cancer progression. Clin Cancer Res.
15:5615–5620. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Su ZZ, Kang DC, Chen Y, Pekarskaya O, Chao
W, Volsky DJ and Fisher PB: Identification and cloning of human
astrocyte genes displaying elevated expression after infection with
HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid
subtraction hybridization, RaSH. Oncogene. 21:3592–3602. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Brown DM and Ruoslahti E: Metadherin, a
cell surface protein in breast tumors that mediates lung
metastasis. Cancer Cell. 5:365–374. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bruix J and Sherman M: Practice Guidelines
Committee, American Association for the Study of Liver Diseases:
Management of hepatocellular carcinoma. Hepatology. 42:1208–1236.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sarkar D and Fisher PB: AEG-1/MTDH/LYRIC:
Clinical significance. Adv Cancer Res. 120:39–74. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yu C, Liu Y, Tan H, Li G, Su Z, Ren S, Zhu
G, Tian Y, Qiu Y and Zhang X: Metadherin regulates metastasis of
squamous cell carcinoma of the head and neck via AKT signalling
pathway-mediated epithelial-mesenchvmal transition. Cancer Lett.
343:258–267. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hu G, Chong RA, Yanu Q, Wei Y, Blanco MA,
Li F, Reiss M, Au JL, Haffty BG and Kang Y: MTDH activation by 8q22
genomic gain promotes chemoresistance and metastasis of
poor-prognosis breast cancer. Cancer Cell. 15:9–20. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhu K, Dai Z, Pan Q, Wang Z, Yang GH, Yu
L, Ding ZB, Shi GM, Ke AW, Yang XR, et al: Metadherin promotes
hepatocellular carcinoma metastasis through induction of
epithelial-mesenchymal transition. Clin Cancer Res. 17:7294–7302.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Madhusudhan KS, Gamanagatti S and Gupta
AK: Imaging and interventions in hilar cholangiocarcinoma: A
review. World J Radiol. 7:28–44. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Poruk KE, Pawlik TM and Weiss MJ:
Perioperative management of hilar cholangiocarcinoma. J
Gastrointest Sura. 19:1889–1899. 2015. View Article : Google Scholar
|
|
16
|
Amin MB: AJCC Cancer Staging Manual. 8th.
American Joint Committee on Cancer. Springer; New York, NY:
2016
|
|
17
|
Wang F, Liu Y and Zhang H: Loss of MTSS1
expression is an independent prognostic factor for hilar
cholangiocarcinoma. Pathol Oncol Res. 19:815–820. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shin HR, Oh JK, Masuyer E, Curado MP,
Bouvard V, Fang YY, Wiangnon S, Sripa B and Hong ST: Epidemiology
of cholangiocarcinoma: An update focusing on risk factors. Cancer
Sci. 101:579–585. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Endo I, House MG, Klimstra DS, Gönen M,
D'Angelica M, Dematteo RP, Fong Y, Blumgart LH and Jarnagin WR:
Clinical significance of intraoperative bile duct margin assessment
for hilar cholangiocarcinoma. Ann Surg Oncol. 15:2104–2112. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Welling TH, Feng M, Wan S, Hwang SY, Volk
ML, Lawrence TS, Zalupski MM and Sonnenday CJ: Neoadjuvant
stereotactic body radiation therapy, capecitabine, and liver
transplantation for unresectable hilar cholangiocarcinoma. Liver
Transpl. 20:81–88. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Otani K, Chijiiwa K, Kai M, Ohuchida J,
Nagano M, Tsuchiya K and Kondo K: Outcome of surgical treatment of
hilar cholangiocarcinoma. J Gastrointest Surg. 12:1033–1040. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu G, Huang X, Cui X, Zhang J, Wei L, Ni
R and Lu C: High SKIP expression is correlated with poor prognosis
and cell proliferation of hepatocellular carcinoma. Med Oncol.
30:5372013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang W, Yang L, Liang S, Liu D, Chen X,
Ma Z, Zhai S, Li P and Wang X: AEG-1 is a target of perifosine and
is over-expressed in gastric dysplasia and cancers. Dig Dis Sci.
58:2873–2880. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yao Y, Gu X, Liu H, Wu G, Yuan D, Yang X
and Song Y: Metadherin regulates proliferation and metastasis via
actin cytoskeletal remodelling in non-small cell lung cancer. Br J
Cancer. 111:355–364. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Emdad L, Darker D, Su ZZ, Randolph A,
Boukerche H, Valerie K and Fisher PB: Activation of the nuclear
factor kappaB pathway by astrocyte elevated gene-1: Implications
for tumor progression and metastasis. Cancer Res. 66:1509–1516.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nikpour M, Emadi-Baygi M, Fischer U,
Niegisch G, Schulz WA and Nikpour P: MTDH/AEG-1 contributes to
central features of the neoplastic phenotype in bladder cancer.
Urol Oncol. 32:670–677. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yu C, Liu Y, Tan H, Li G, Su Z, Ren S, Zhu
G, Tian Y, Qiu Y and Zhang X: Metadherin regulates metastasis of
squamous cell carcinoma of the head and neck via AKT signaling
pathway-mediated epithelial-mesenchymal transition. Cancer Lett.
343:258–267. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hui AB, Bruce JP, Alajez NM, Shi W, Yue S,
Perez-Ordonez B, Xu W, O'Sullivan B, Waldron J, Cummings B, et al:
Significance of dysregulated metadherin and microRNA-375 in head
and neck cancer. Clin Cancer Res. 17:7539–7550. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Singal AG, Conjeevaram HS, Volk ML, Fu S,
Fontana RJ, Askari F, Su GL, Lok AS and Marrero JA: Effectiveness
of hepatocellular carcinoma surveillance in patients with
cirrhosis. Cancer Epidemiol Biomarkers Prev. 21:793–799. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Luo Z, Hu X, Xiong H, Qiu H, Yuan X, Zhu
F, Wang Y and Zou Y: A polysaccharide from Huaier induced apoptosis
in MCF-7 breast cancer cells via down-regulation of MTDH protein.
Carbohydr Polym. 151:1027–1033. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang Y, Klijn JG, Zhang Y, Sieuwerts AM,
Look MP, Yang F, Talantov D, Timmermans M, Meijer-van Gelder ME, Yu
J, et al: Gene-expression profiles to predict distant metastasis of
lymph-node-negative primary breast cancer. Lancet. 365:671–679.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chan SL, Mo F, Johnson PJ, Siu DY, Chan
MH, Lau WY, Lai PB, Lam CW, Yeo W and Yu SC: Performance of serum
α-fetoprotein levels in the diagnosis of hepatocellular carcinoma
in patients with a hepatic mass. HPB (Oxford). 16:366–372. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gopal P, Yopp AC, Waljee AK, Chiang J,
Nehra M, Kandunoori P and Singal AG: Factors that affect accuracy
of α-fetoprotein test in detection of hepatocellular carcinoma in
patients with cirrhosis. Clin Gastroenterol Hepatol. 12:870–877.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Moore RF, Sholl AB, Kidd L, Al-Qurayshi Z,
Tsumagari K, Emejulu OM, Kholmatov R, Friedlander P, Abd Elmageed
ZY and Kandil E: Metadherin expression is associated with
extrathyroidal extension in papillary thyroid cancer patients. Ann
Surg Oncol. 23:2883–2888. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yu J, Wang JG, Zhang L, Yang HP, Wang L,
Ding D, Chen Q, Yang WL, Ren KH, Zhou DM, et al: MicroRNA-320a
inhibits breast cancer metastasis by targeting metadherin.
Oncotarget. 7:38612–38625. 2016.PubMed/NCBI
|
|
36
|
Liu Y, Kong X, Li X, Li B and Yang Q:
Knockdown of metadherin inhibits angiogenesis in breast cancer. Int
J Oncol. 46:2459–2466. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yu C, Chen K, Zheng H, Guo X, Jia W, Li M,
Zeng M, Li J and Song L: Overexpression of astrocyte elevated
gene-1 (AEG-1) is associated with esophageal squamous cell
carcinoma (ESCC) progression and pathogenesis. Carcinogenesis.
30:894–901. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wei YB, Guo Q, Gao YL, Yan B, Wang Z, Yang
JR and Liu W: Repression of metadherin inhibits biological behavior
of prostate cancer cells and enhances their sensitivity to
cisplatin. Mol Med Rep. 12:226–232. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Huang S, Wu B, Li D, Zhou W, Deng G, Zhang
K and Li Y: Knockdown of astrocyte elevated gene-1 inhibits tumor
growth and modifies microRNAs expression profiles in human
colorectal cancer cells. Biochem Biophys Res Commun. 444:338–345.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhou CX, Wang CL, Yu AL, Wang QY, Zhan MN,
Tang J, Gong XF, Yin QQ, He M, He JR, et al: MiR-630 suppresses
breast cancer progression by targeting metadherin. Oncotarget.
7:1288–1299. 2016.PubMed/NCBI
|
